1. Market Research
  2. > Pathology Industry

Breast Cancer Industry, May 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Mammography, Therapeutics, Pharmaceutical, Molecular Diagnostic, Vaccine, Cancer Diagnostic, Radiological Equipment, Antibody, Biomarker, Biopsy Device, Healthcare, Oncology, Biosimilar, Medical, Antigen, Biochip, Cancer Drug, Radiation Therapy, Therapy.


 
1-10 of 82 reports for Breast Cancer

Purchase Reports From Reputable Market Research Publishers

Breast Imaging Market by Type, Non-ionizing Technologies - Forecast to 2021

Breast Imaging Market by Type, Non-ionizing Technologies - Forecast to 2021

  • $ 4 650
  • Industry report
  • May 2016
  • by MarketsandMarkets

The global breast imaging market is estimated to grow at a CAGR of 8.5% from 2016 to 2021. Although developed regions (such as North America and Europe) held large shares in the breast imaging market in ...

Circulating Tumor Cells Market Analysis By Technology (Filtration, Centrifugation, Immunological & Immunomagnetic, Optical, Molecular, Tumor Cell Enrichment & Detection), By Application (Prostate Cancer, Breast Cancer, Colorectal Cancer) and Segment Forec

Circulating Tumor Cells Market Analysis By Technology (Filtration, Centrifugation, Immunological & Immunomagnetic, Optical, Molecular, Tumor Cell Enrichment & Detection), By Application (Prostate Cancer, Breast Cancer, Colorectal Cancer) and Segment Forec

  • $ 4 700
  • Industry report
  • May 2016
  • by Grand View Research

Global circulating tumor cells market is expected to reach USD 2.28 billion by 2020. Growing prevalence of cancer has heightened the need for effective and early diagnosis. Circulating tumor cells cate ...

Global Breast Cancer Partnering 2010 to 2016

Global Breast Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • May 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Breast Cancer Treatment Drug Companies in China

Breast Cancer Treatment Drug Companies in China

  • $ 1 800
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Breast Cancer Treatment Drug industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions ...

Breast Cancer Treatment Drug Industry Forecasts - China Focus

Breast Cancer Treatment Drug Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Breast Cancer Treatment Drug industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

Breast Cancer Treatment Drug Markets in China

Breast Cancer Treatment Drug Markets in China

  • $ 4 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Breast Cancer: Update Bulletin [March 2016]

Breast Cancer: Update Bulletin [March 2016]

  • $ 1 040
  • Industry report
  • March 2016
  • by Firstword Pharma

In this update KOLs reflect on the promising Phase Ib data for Roche’s monoclonal antibody (mAb), atezolizumab, in combination with nab-paclitaxel for patients with metastatic triple- negative breast ...

Tumor Ablation Market Size & Forecast By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Cancer), And Trend Analysis From 2015 To

Tumor Ablation Market Size & Forecast By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Cancer), And Trend Analysis From 2015 To

  • $ 4 700
  • Industry report
  • February 2016
  • by Grand View Research

Global tumor ablation market is expected to reach USD 1.5 billion by 2022, according to a new study by Grand View Research Inc. Rising prevalence of different forms of cancer and increasing technological ...

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

  • $ 6 995
  • Industry report
  • February 2016
  • by GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes Summary The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 ...

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • $ 4 995
  • Industry report
  • February 2016
  • by GBI Research

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence Summary Breast cancer, a malignant neoplasm, is the second-most ...

About 7 900 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2014
    186 pages
  • Breast Cancer  

    Cancer  

    Therapy  

  • United States  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.